Article

MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study.

2024-07-26

Abstract excerpt

A “watch and wait” strategy, delaying treatment until active disease manifests, is adopted for most CLL cases; however prognostic models incorporating biomarkers have shown to be useful to predict treatment requirement. In our prospective O-CLL1 study including 224 patients, we investigated the predictive role of 513 microRNAs (miRNAs) on time to first treatment (TTFT). In the context of this study six well-establ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7688ca82-2621-545d-be6c-839b8a43d775
DOI: 10.20944/preprints202407.2194.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study.DOI 10.20944/preprints202407.2194.v1Read

MicroRNAs: Potential prognostic and theranostic biomarkers in chronic lymphocytic leukemiaSemantic proximity Read

microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters.Semantic proximity Read

A Molecular Score by Quantitative PCR as a New Prognostic Tool at Diagnosis for Chronic Lymphocytic Leukemia PatientsSemantic proximity Read

Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemiaSemantic proximity Read

State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemiaSemantic proximity Read

Role of microRNAs in Chronic Lymphocytic LeukemiaSemantic proximity Read

Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group.Semantic proximity Read

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.Semantic proximity Read

Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment.Semantic proximity Read

The Role of MicroRNAs, CircRNAs, and LncRNAs in Chronic Lymphocytic LeukemiaSemantic proximity Read

MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemiaSemantic proximity Read

Role of microRNA in chronic lymphocytic leukemia onset and progressionSemantic proximity Read